BioLuminate's Smart Probe Breast Cancer Detection Trials Start In Early 2001
This article was originally published in The Gray Sheet
Executive Summary
San Jose-based BioLuminate expects to be profitable in 2003, immediately following the commercial release of its Smart Probe breast cancer detection diagnostic tool. The privately held start-up began operations in April 2000.